40% supply-gap(0) + 25% price-variation(0) + 20% low-competition(76) + 15% supply-disruption(0), damped by confidence(65). Higher = more attractive, less crowded opportunity.

Market saturation

9 canonical companies and 14 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

Only 0 trusted price points; variation not scored (low data).

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: sparse price data, no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules